Global Neuromuscular Disease Therapeutics Market 2023-2027

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	163 Pages	TechNavio	October, 2023	INF18250142

Best Price Guarantee
Price	from $2,500
Length	163 Pages
Publisher	TechNavio
Published Date	October, 2023
SKU	INF18250142

Neuromuscular Disease Therapeutics Market 2023-2027

The neuromuscular disease therapeutics market is forecasted to grow by USD 6513.28 million during 2022-2027, accelerating at a CAGR of 10.3% during the forecast period. The report on the neuromuscular disease therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by novel approvals for neuromuscular disease therapeutics, growing newborn screening tests, and huge unmet need for neuromuscular disease therapeutics.

Technavio's neuromuscular disease therapeutics market is segmented as below:

By Type

Biologics
Small molecules

By End-user

Hospitals
Clinics
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the technological advances in neuromuscular disease therapy as one of the prime reasons driving the neuromuscular disease therapeutics market growth during the next few years. Also, inherited nature of neuromuscular diseases and increasing research on developing therapeutics for neuromuscular disease will lead to sizable demand in the market.

The report on the neuromuscular disease therapeutics market covers the following areas:

Neuromuscular disease therapeutics market sizing
Neuromuscular disease therapeutics market forecast
Neuromuscular disease therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading neuromuscular disease therapeutics market vendors that include Aquestive Therapeutics Inc., Bausch Health Companies Inc., Biogen Inc., Brainstorm Cell Therapeutics Inc., Cytokinetics Inc., F. Hoffmann La Roche Ltd., Ionis Pharmaceuticals Inc., Mitsubishi Chemical Corp., Mylan NV, Nippon Shinyaku Co. Ltd., Novartis AG, Pfizer Inc., PTC Therapeutics Inc., Sanofi, Sarepta Therapeutics Inc, SGPharma Pvt. Ltd., Sun Pharmaceutical Industries Ltd., Troikaa Pharmaceuticals Ltd., Viatris Inc., and AFM-Telethon. Also, the neuromuscular disease therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary €“ Chart on Market Overview; Exhibit 02: Executive Summary €“ Data Table on Market Overview; Exhibit 03: Executive Summary €“ Chart on Global Market Characteristics; Exhibit 04: Executive Summary €“ Chart on Market By Geographical Landscape; Exhibit 05: Executive Summary €“ Chart on Market Segmentation by Type; Exhibit 06: Executive Summary €“ Chart on Market Segmentation by End-user; Exhibit 07: Executive Summary €“ Chart on Incremental Growth; Exhibit 08: Executive Summary €“ Data Table on Incremental Growth; Exhibit 09: Executive Summary €“ Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 10: Parent market; Exhibit 11: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 12: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 13: Market segments; 3.3 Market size 2022; 3.4 Market outlook: Forecast for 2022-2027; Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million); Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million); Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%); Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size: 4.1 Global neuromuscular disease therapeutics market 2017 - 2021; Exhibit 18: Historic Market Size €“ Data Table on global neuromuscular disease therapeutics market 2017 - 2021 ($ million); 4.2 Type Segment Analysis 2017 - 2021; Exhibit 19: Historic Market Size €“ Type Segment 2017 - 2021 ($ million); 4.3 End-user Segment Analysis 2017 - 2021; Exhibit 20: Historic Market Size €“ End-user Segment 2017 - 2021 ($ million); 4.4 Geography Segment Analysis 2017 - 2021; Exhibit 21: Historic Market Size €“ Geography Segment 2017 - 2021 ($ million); 4.5 Country Segment Analysis 2017 - 2021; Exhibit 22: Historic Market Size €“ Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Exhibit 23: Five forces analysis - Comparison between 2022 and 2027; 5.2 Bargaining power of buyers; Exhibit 24: Chart on Bargaining power of buyers €“ Impact of key factors 2022 and 2027; 5.3 Bargaining power of suppliers; Exhibit 25: Bargaining power of suppliers €“ Impact of key factors in 2022 and 2027; 5.4 Threat of new entrants; Exhibit 26: Threat of new entrants €“ Impact of key factors in 2022 and 2027; 5.5 Threat of substitutes; Exhibit 27: Threat of substitutes €“ Impact of key factors in 2022 and 2027; 5.6 Threat of rivalry; Exhibit 28: Threat of rivalry €“ Impact of key factors in 2022 and 2027; 5.7 Market condition; Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Type: 6.1 Market segments; Exhibit 30: Chart on Type - Market share 2022-2027 (%); Exhibit 31: Data Table on Type - Market share 2022-2027 (%); 6.2 Comparison by Type; Exhibit 32: Chart on Comparison by Type; Exhibit 33: Data Table on Comparison by Type; 6.3 Biologics - Market size and forecast 2022-2027; Exhibit 34: Chart on Biologics - Market size and forecast 2022-2027 ($ million); Exhibit 35: Data Table on Biologics - Market size and forecast 2022-2027 ($ million); Exhibit 36: Chart on Biologics - Year-over-year growth 2022-2027 (%); Exhibit 37: Data Table on Biologics - Year-over-year growth 2022-2027 (%); 6.4 Small molecules - Market size and forecast 2022-2027; Exhibit 38: Chart on Small molecules - Market size and forecast 2022-2027 ($ million); Exhibit 39: Data Table on Small molecules - Market size and forecast 2022-2027 ($ million); Exhibit 40: Chart on Small molecules - Year-over-year growth 2022-2027 (%); Exhibit 41: Data Table on Small molecules - Year-over-year growth 2022-2027 (%); 6.5 Market opportunity by Type; Exhibit 42: Market opportunity by Type ($ million); Exhibit 43: Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by End-user: 7.1 Market segments; Exhibit 44: Chart on End-user - Market share 2022-2027 (%); Exhibit 45: Data Table on End-user - Market share 2022-2027 (%); 7.2 Comparison by End-user; Exhibit 46: Chart on Comparison by End-user; Exhibit 47: Data Table on Comparison by End-user; 7.3 Hospitals - Market size and forecast 2022-2027; Exhibit 48: Chart on Hospitals - Market size and forecast 2022-2027 ($ million); Exhibit 49: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million); Exhibit 50: Chart on Hospitals - Year-over-year growth 2022-2027 (%); Exhibit 51: Data Table on Hospitals - Year-over-year growth 2022-2027 (%); 7.4 Clinics - Market size and forecast 2022-2027; Exhibit 52: Chart on Clinics - Market size and forecast 2022-2027 ($ million); Exhibit 53: Data Table on Clinics - Market size and forecast 2022-2027 ($ million); Exhibit 54: Chart on Clinics - Year-over-year growth 2022-2027 (%); Exhibit 55: Data Table on Clinics - Year-over-year growth 2022-2027 (%); 7.5 Others - Market size and forecast 2022-2027; Exhibit 56: Chart on Others - Market size and forecast 2022-2027 ($ million); Exhibit 57: Data Table on Others - Market size and forecast 2022-2027 ($ million); Exhibit 58: Chart on Others - Year-over-year growth 2022-2027 (%); Exhibit 59: Data Table on Others - Year-over-year growth 2022-2027 (%); 7.6 Market opportunity by End-user; Exhibit 60: Market opportunity by End-user ($ million); Exhibit 61: Data Table on Market opportunity by End-user ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%); Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%); 9.2 Geographic comparison; Exhibit 65: Chart on Geographic comparison; Exhibit 66: Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2022-2027; Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million); Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million); Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%); Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%); 9.4 Europe - Market size and forecast 2022-2027; Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million); Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million); Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%); Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%); 9.5 Asia - Market size and forecast 2022-2027; Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million); Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million); Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%); Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%); 9.6 Rest of World (ROW) - Market size and forecast 2022-2027; Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million); Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million); Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%); Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%); 9.7 US - Market size and forecast 2022-2027; Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million); Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million); Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%); Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%); 9.8 Canada - Market size and forecast 2022-2027; Exhibit 87: Chart on Canada - Market size and forecast 2022-2027 ($ million); Exhibit 88: Data Table on Canada - Market size and forecast 2022-2027 ($ million); Exhibit 89: Chart on Canada - Year-over-year growth 2022-2027 (%); Exhibit 90: Data Table on Canada - Year-over-year growth 2022-2027 (%); 9.9 Germany - Market size and forecast 2022-2027; Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million); Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million); Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%); Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%); 9.10 UK - Market size and forecast 2022-2027; Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million); Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million); Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%); Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%); 9.11 China - Market size and forecast 2022-2027; Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million); Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million); Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%); Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%); 9.12 Market opportunity By Geographical Landscape; Exhibit 103: Market opportunity By Geographical Landscape ($ million); Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Exhibit 105: Impact of drivers and challenges in 2022 and 2027; 10.4 Market trends
11 Vendor Landscape: 11.1 Overview; 11.2 Vendor landscape; Exhibit 106: Overview on Criticality of inputs and Factors of differentiation; 11.3 Landscape disruption; Exhibit 107: Overview on factors of disruption; 11.4 Industry risks; Exhibit 108: Impact of key risks on business
12 Vendor Analysis: 12.1 Vendors covered; Exhibit 109: Vendors covered; 12.2 Market positioning of vendors; Exhibit 110: Matrix on vendor position and classification; 12.3 AFM-Telethon; Exhibit 111: AFM-Telethon - Overview; Exhibit 112: AFM-Telethon - Product / Service; Exhibit 113: AFM-Telethon - Key offerings; 12.4 Aquestive Therapeutics Inc.; Exhibit 114: Aquestive Therapeutics Inc. - Overview; Exhibit 115: Aquestive Therapeutics Inc. - Business segments; Exhibit 116: Aquestive Therapeutics Inc. - Key offerings; Exhibit 117: Aquestive Therapeutics Inc. - Segment focus; 12.5 Biogen Inc.; Exhibit 118: Biogen Inc. - Overview; Exhibit 119: Biogen Inc. - Product / Service; Exhibit 120: Biogen Inc. - Key offerings; 12.6 Brainstorm Cell Therapeutics Inc.; Exhibit 121: Brainstorm Cell Therapeutics Inc. - Overview; Exhibit 122: Brainstorm Cell Therapeutics Inc. - Product / Service; Exhibit 123: Brainstorm Cell Therapeutics Inc. - Key offerings; 12.7 F. Hoffmann La Roche Ltd.; Exhibit 124: F. Hoffmann La Roche Ltd. - Overview; Exhibit 125: F. Hoffmann La Roche Ltd. - Business segments; Exhibit 126: F. Hoffmann La Roche Ltd. - Key news; Exhibit 127: F. Hoffmann La Roche Ltd. - Key offerings; Exhibit 128: F. Hoffmann La Roche Ltd. - Segment focus; 12.8 Ionis Pharmaceuticals Inc.; Exhibit 129: Ionis Pharmaceuticals Inc. - Overview; Exhibit 130: Ionis Pharmaceuticals Inc. - Business segments; Exhibit 131: Ionis Pharmaceuticals Inc. - Key news; Exhibit 132: Ionis Pharmaceuticals Inc. - Key offerings; Exhibit 133: Ionis Pharmaceuticals Inc. - Segment focus; 12.9 Mitsubishi Chemical Corp.; Exhibit 134: Mitsubishi Chemical Corp. - Overview; Exhibit 135: Mitsubishi Chemical Corp. - Business segments; Exhibit 136: Mitsubishi Chemical Corp. - Key offerings; Exhibit 137: Mitsubishi Chemical Corp. - Segment focus; 12.10 Nippon Shinyaku Co. Ltd.; Exhibit 138: Nippon Shinyaku Co. Ltd. - Overview; Exhibit 139: Nippon Shinyaku Co. Ltd. - Business segments; Exhibit 140: Nippon Shinyaku Co. Ltd. - Key offerings; Exhibit 141: Nippon Shinyaku Co. Ltd. - Segment focus; 12.11 Novartis AG; Exhibit 142: Novartis AG - Overview; Exhibit 143: Novartis AG - Business segments; Exhibit 144: Novartis AG - Key offerings; Exhibit 145: Novartis AG - Segment focus; 12.12 Pfizer Inc.; Exhibit 146: Pfizer Inc. - Overview; Exhibit 147: Pfizer Inc. - Product / Service; Exhibit 148: Pfizer Inc. - Key news; Exhibit 149: Pfizer Inc. - Key offerings; 12.13 PTC Therapeutics Inc.; Exhibit 150: PTC Therapeutics Inc. - Overview; Exhibit 151: PTC Therapeutics Inc. - Product / Service; Exhibit 152: PTC Therapeutics Inc. - Key offerings; 12.14 Sanofi; Exhibit 153: Sanofi - Overview; Exhibit 154: Sanofi - Business segments; Exhibit 155: Sanofi - Key news; Exhibit 156: Sanofi - Key offerings; Exhibit 157: Sanofi - Segment focus; 12.15 Sarepta Therapeutics Inc; Exhibit 158: Sarepta Therapeutics Inc - Overview; Exhibit 159: Sarepta Therapeutics Inc - Product / Service; Exhibit 160: Sarepta Therapeutics Inc - Key offerings; 12.16 SGPharma Pvt. Ltd.; Exhibit 161: SGPharma Pvt. Ltd. - Overview; Exhibit 162: SGPharma Pvt. Ltd. - Product / Service; Exhibit 163: SGPharma Pvt. Ltd. - Key offerings; 12.17 Viatris Inc.; Exhibit 164: Viatris Inc. - Overview; Exhibit 165: Viatris Inc. - Business segments; Exhibit 166: Viatris Inc. - Key news; Exhibit 167: Viatris Inc. - Key offerings; Exhibit 168: Viatris Inc. - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Exhibit 169: Inclusions checklist; Exhibit 170: Exclusions checklist; 13.3 Currency conversion rates for US$; Exhibit 171: Currency conversion rates for US$; 13.4 Research methodology; Exhibit 172: Research methodology; Exhibit 173: Validation techniques employed for market sizing; Exhibit 174: Information sources; 13.5 List of abbreviations; Exhibit 175: List of abbreviations
Exhibits:: Exhibits1: Executive Summary €“ Chart on Market Overview; Exhibits2: Executive Summary €“ Data Table on Market Overview; Exhibits3: Executive Summary €“ Chart on Global Market Characteristics; Exhibits4: Executive Summary €“ Chart on Market By Geographical Landscape; Exhibits5: Executive Summary €“ Chart on Market Segmentation by Type; Exhibits6: Executive Summary €“ Chart on Market Segmentation by End-user; Exhibits7: Executive Summary €“ Chart on Incremental Growth; Exhibits8: Executive Summary €“ Data Table on Incremental Growth; Exhibits9: Executive Summary €“ Chart on Vendor Market Positioning; Exhibits10: Parent market; Exhibits11: Market Characteristics; Exhibits12: Offerings of vendors included in the market definition; Exhibits13: Market segments; Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million); Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million); Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%); Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%); Exhibits18: Historic Market Size €“ Data Table on global neuromuscular disease therapeutics market 2017 - 2021 ($ million); Exhibits19: Historic Market Size €“ Type Segment 2017 - 2021 ($ million); Exhibits20: Historic Market Size €“ End-user Segment 2017 - 2021 ($ million); Exhibits21: Historic Market Size €“ Geography Segment 2017 - 2021 ($ million); Exhibits22: Historic Market Size €“ Country Segment 2017 - 2021 ($ million); Exhibits23: Five forces analysis - Comparison between 2022 and 2027; Exhibits24: Chart on Bargaining power of buyers €“ Impact of key factors 2022 and 2027; Exhibits25: Bargaining power of suppliers €“ Impact of key factors in 2022 and 2027; Exhibits26: Threat of new entrants €“ Impact of key factors in 2022 and 2027; Exhibits27: Threat of substitutes €“ Impact of key factors in 2022 and 2027; Exhibits28: Threat of rivalry €“ Impact of key factors in 2022 and 2027; Exhibits29: Chart on Market condition - Five forces 2022 and 2027; Exhibits30: Chart on Type - Market share 2022-2027 (%); Exhibits31: Data Table on Type - Market share 2022-2027 (%); Exhibits32: Chart on Comparison by Type; Exhibits33: Data Table on Comparison by Type; Exhibits34: Chart on Biologics - Market size and forecast 2022-2027 ($ million); Exhibits35: Data Table on Biologics - Market size and forecast 2022-2027 ($ million); Exhibits36: Chart on Biologics - Year-over-year growth 2022-2027 (%); Exhibits37: Data Table on Biologics - Year-over-year growth 2022-2027 (%); Exhibits38: Chart on Small molecules - Market size and forecast 2022-2027 ($ million); Exhibits39: Data Table on Small molecules - Market size and forecast 2022-2027 ($ million); Exhibits40: Chart on Small molecules - Year-over-year growth 2022-2027 (%); Exhibits41: Data Table on Small molecules - Year-over-year growth 2022-2027 (%); Exhibits42: Market opportunity by Type ($ million); Exhibits43: Data Table on Market opportunity by Type ($ million); Exhibits44: Chart on End-user - Market share 2022-2027 (%); Exhibits45: Data Table on End-user - Market share 2022-2027 (%); Exhibits46: Chart on Comparison by End-user; Exhibits47: Data Table on Comparison by End-user; Exhibits48: Chart on Hospitals - Market size and forecast 2022-2027 ($ million); Exhibits49: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million); Exhibits50: Chart on Hospitals - Year-over-year growth 2022-2027 (%); Exhibits51: Data Table on Hospitals - Year-over-year growth 2022-2027 (%); Exhibits52: Chart on Clinics - Market size and forecast 2022-2027 ($ million); Exhibits53: Data Table on Clinics - Market size and forecast 2022-2027 ($ million); Exhibits54: Chart on Clinics - Year-over-year growth 2022-2027 (%); Exhibits55: Data Table on Clinics - Year-over-year growth 2022-2027 (%); Exhibits56: Chart on Others - Market size and forecast 2022-2027 ($ million); Exhibits57: Data Table on Others - Market size and forecast 2022-2027 ($ million); Exhibits58: Chart on Others - Year-over-year growth 2022-2027 (%); Exhibits59: Data Table on Others - Year-over-year growth 2022-2027 (%); Exhibits60: Market opportunity by End-user ($ million); Exhibits61: Data Table on Market opportunity by End-user ($ million); Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%); Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%); Exhibits65: Chart on Geographic comparison; Exhibits66: Data Table on Geographic comparison; Exhibits67: Chart on North America - Market size and forecast 2022-2027 ($ million); Exhibits68: Data Table on North America - Market size and forecast 2022-2027 ($ million); Exhibits69: Chart on North America - Year-over-year growth 2022-2027 (%); Exhibits70: Data Table on North America - Year-over-year growth 2022-2027 (%); Exhibits71: Chart on Europe - Market size and forecast 2022-2027 ($ million); Exhibits72: Data Table on Europe - Market size and forecast 2022-2027 ($ million); Exhibits73: Chart on Europe - Year-over-year growth 2022-2027 (%); Exhibits74: Data Table on Europe - Year-over-year growth 2022-2027 (%); Exhibits75: Chart on Asia - Market size and forecast 2022-2027 ($ million); Exhibits76: Data Table on Asia - Market size and forecast 2022-2027 ($ million); Exhibits77: Chart on Asia - Year-over-year growth 2022-2027 (%); Exhibits78: Data Table on Asia - Year-over-year growth 2022-2027 (%); Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million); Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million); Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%); Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%); Exhibits83: Chart on US - Market size and forecast 2022-2027 ($ million); Exhibits84: Data Table on US - Market size and forecast 2022-2027 ($ million); Exhibits85: Chart on US - Year-over-year growth 2022-2027 (%); Exhibits86: Data Table on US - Year-over-year growth 2022-2027 (%); Exhibits87: Chart on Canada - Market size and forecast 2022-2027 ($ million); Exhibits88: Data Table on Canada - Market size and forecast 2022-2027 ($ million); Exhibits89: Chart on Canada - Year-over-year growth 2022-2027 (%); Exhibits90: Data Table on Canada - Year-over-year growth 2022-2027 (%); Exhibits91: Chart on Germany - Market size and forecast 2022-2027 ($ million); Exhibits92: Data Table on Germany - Market size and forecast 2022-2027 ($ million); Exhibits93: Chart on Germany - Year-over-year growth 2022-2027 (%); Exhibits94: Data Table on Germany - Year-over-year growth 2022-2027 (%); Exhibits95: Chart on UK - Market size and forecast 2022-2027 ($ million); Exhibits96: Data Table on UK - Market size and forecast 2022-2027 ($ million); Exhibits97: Chart on UK - Year-over-year growth 2022-2027 (%); Exhibits98: Data Table on UK - Year-over-year growth 2022-2027 (%); Exhibits99: Chart on China - Market size and forecast 2022-2027 ($ million); Exhibits100: Data Table on China - Market size and forecast 2022-2027 ($ million); Exhibits101: Chart on China - Year-over-year growth 2022-2027 (%); Exhibits102: Data Table on China - Year-over-year growth 2022-2027 (%); Exhibits103: Market opportunity By Geographical Landscape ($ million); Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits105: Impact of drivers and challenges in 2022 and 2027; Exhibits106: Overview on Criticality of inputs and Factors of differentiation; Exhibits107: Overview on factors of disruption; Exhibits108: Impact of key risks on business; Exhibits109: Vendors covered; Exhibits110: Matrix on vendor position and classification; Exhibits111: AFM-Telethon - Overview; Exhibits112: AFM-Telethon - Product / Service; Exhibits113: AFM-Telethon - Key offerings; Exhibits114: Aquestive Therapeutics Inc. - Overview; Exhibits115: Aquestive Therapeutics Inc. - Business segments; Exhibits116: Aquestive Therapeutics Inc. - Key offerings; Exhibits117: Aquestive Therapeutics Inc. - Segment focus; Exhibits118: Biogen Inc. - Overview; Exhibits119: Biogen Inc. - Product / Service; Exhibits120: Biogen Inc. - Key offerings; Exhibits121: Brainstorm Cell Therapeutics Inc. - Overview; Exhibits122: Brainstorm Cell Therapeutics Inc. - Product / Service; Exhibits123: Brainstorm Cell Therapeutics Inc. - Key offerings; Exhibits124: F. Hoffmann La Roche Ltd. - Overview; Exhibits125: F. Hoffmann La Roche Ltd. - Business segments; Exhibits126: F. Hoffmann La Roche Ltd. - Key news; Exhibits127: F. Hoffmann La Roche Ltd. - Key offerings; Exhibits128: F. Hoffmann La Roche Ltd. - Segment focus; Exhibits129: Ionis Pharmaceuticals Inc. - Overview; Exhibits130: Ionis Pharmaceuticals Inc. - Business segments; Exhibits131: Ionis Pharmaceuticals Inc. - Key news; Exhibits132: Ionis Pharmaceuticals Inc. - Key offerings; Exhibits133: Ionis Pharmaceuticals Inc. - Segment focus; Exhibits134: Mitsubishi Chemical Corp. - Overview; Exhibits135: Mitsubishi Chemical Corp. - Business segments; Exhibits136: Mitsubishi Chemical Corp. - Key offerings; Exhibits137: Mitsubishi Chemical Corp. - Segment focus; Exhibits138: Nippon Shinyaku Co. Ltd. - Overview; Exhibits139: Nippon Shinyaku Co. Ltd. - Business segments; Exhibits140: Nippon Shinyaku Co. Ltd. - Key offerings; Exhibits141: Nippon Shinyaku Co. Ltd. - Segment focus; Exhibits142: Novartis AG - Overview; Exhibits143: Novartis AG - Business segments; Exhibits144: Novartis AG - Key offerings; Exhibits145: Novartis AG - Segment focus; Exhibits146: Pfizer Inc. - Overview; Exhibits147: Pfizer Inc. - Product / Service; Exhibits148: Pfizer Inc. - Key news; Exhibits149: Pfizer Inc. - Key offerings; Exhibits150: PTC Therapeutics Inc. - Overview; Exhibits151: PTC Therapeutics Inc. - Product / Service; Exhibits152: PTC Therapeutics Inc. - Key offerings; Exhibits153: Sanofi - Overview; Exhibits154: Sanofi - Business segments; Exhibits155: Sanofi - Key news; Exhibits156: Sanofi - Key offerings; Exhibits157: Sanofi - Segment focus; Exhibits158: Sarepta Therapeutics Inc - Overview; Exhibits159: Sarepta Therapeutics Inc - Product / Service; Exhibits160: Sarepta Therapeutics Inc - Key offerings; Exhibits161: SGPharma Pvt. Ltd. - Overview; Exhibits162: SGPharma Pvt. Ltd. - Product / Service; Exhibits163: SGPharma Pvt. Ltd. - Key offerings; Exhibits164: Viatris Inc. - Overview; Exhibits165: Viatris Inc. - Business segments; Exhibits166: Viatris Inc. - Key news; Exhibits167: Viatris Inc. - Key offerings; Exhibits168: Viatris Inc. - Segment focus; Exhibits169: Inclusions checklist; Exhibits170: Exclusions checklist; Exhibits171: Currency conversion rates for US$; Exhibits172: Research methodology; Exhibits173: Validation techniques employed for market sizing; Exhibits174: Information sources; Exhibits175: List of abbreviations